Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep
Status:
Active, not recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
This study aims to determine whether, compared with placebo, the nighttime administration of
a intravenous dexmedetomidine is effective at inducing sleep and preventing postoperative
delirium in extubated post-cardiac surgical patients.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
National Institute on Aging (NIA) National Institutes of Health (NIH)